verified SJR 0,734 · Q2 • database Scopus / SJR & Web of Science & DOAJ indexed

United Kingdom · John Wiley and Sons Ltd

workspace_premium Q2 — Neuroscience (miscellaneous) verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Parkinson's Disease

Parkinson's Disease is a journal indexed in SJR in Neuroscience (miscellaneous) and Neurology (clinical) with an H index of 63. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1170 €. The scope of the journal is focused on parkinson's disease. It has an SJR impact factor of 0,734 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,734.

ISSN: 2090-8083

Publisher: John Wiley and Sons Ltd

Category: Neuroscience (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,734 Q2

H-index 63

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

18 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

1.170 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,734

H-index

Docs (year)

Docs 3y

128

Total refs

957

Cites 3y

352

Citable 3y

128

Cites/Doc 2y

2.28

Ref/Doc

50.37

Immediate OA

1170 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Changes in Vowel Articulation with Subthalamic Nucleus Deep Brain Stimulation in Dysarthric Speakers with Parkinson's Disease

Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson's Disease

Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease

Comparing Balance Performance on Force Platform Measures in Individuals with Parkinson's Disease and Healthy Adults

Combining a Cognitive Concurrent Task with a Motor or Motor-Cognitive Task: Which Is Better to Differentiate Levels of Affectation in Parkinson's Disease?

Cognitive Stimulation for Individuals with Parkinson's Disease Dementia Living in Long-Term Care: Preliminary Data from a Randomized Crossover Pilot Study

Cognition Deficits in Parkinson's Disease: Mechanisms and Treatment

Clinical Pain and Neuropsychological Functioning in Parkinson's Disease: Are They Related?

Clinical Features Associated with Frozen Shoulder Syndrome in Parkinson's Disease

Clinical Aspects and Management of Levodopa-Induced Dyskinesia

Clinical and Epidemiological Factors Associated with Mortality in Parkinson's Disease in a Brazilian Cohort

Changes to Intermediary Metabolites in Sporadic andLRRK2Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy

SHOW MORE ARTICLES

Changes of Retina Are Not Involved in the Genesis of Visual Hallucinations in Parkinson's Disease

17a-Ethynyl-androst-5-ene-3beta,7beta,17beta-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease

Can the Executive Control Network be Used to Diagnose Parkinson's Disease and as an Efficacy Indicator of Deep Brain Stimulation?

Blue Light Therapy Glasses in Parkinson's Disease: Patients' Experience

Blindfolded Balance Training in Patients with Parkinson's Disease: A Sensory-Motor Strategy to Improve the Gait

Association of Motor and Cognitive Symptoms with Health-Related Quality of Life and Caregiver Burden in a German Cohort of Advanced Parkinson's Disease Patients

Association of aBACE1Gene Polymorphism with Parkinson's Disease in a Norwegian Population

Are Patients Ready for "EARLYSTIM"? Attitudes towards Deep Brain Stimulation among Female and Male Patients with Moderately Advanced Parkinson's Disease

An Integrated Review of Psychological Stress in Parkinson's Disease: Biological Mechanisms and Symptom and Health Outcomes

Altered Spontaneous Brain Activity in Cortical and Subcortical Regions in Parkinson's Disease

Age Matters: Objective Gait Assessment in Early Parkinson's Disease Using an RGB-D Camera

Accuracy of Markerless 3D Motion Capture Evaluation to Differentiate between On/Off Status in Parkinson's Disease after Deep Brain Stimulation

FAQs

Parkinson's Disease has an SJR of 0,734 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 1170 EUR.

The acceptance rate recorded for Parkinson's Disease is 30%.

Parkinson's Disease

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Parkinson's Disease?

What is the APC / publication cost?

What is the acceptance rate?